Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Revista Medica De Chile|February 7, 2019
[Survival of patients with advanced HER2+ breast cancer. Analysis of a cancer center database]Cesar Sánchez, Francisco Domínguez, Héctor Galindo, et al.Ecancermedicalscience|February 28, 2024
Palbociclib in advanced stage hormone receptor-positive breast cancer: real-world data from a Chilean multicentre registryBenjamín Walbaum, José Miguel Reyes, Pablo Rodriguez, et al.Breast Cancer Research and Treatment|July 10, 2021
Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patientsBenjamin Walbaum, Klaus Puschel, Lidia Medina, et al.Revista Medica De Chile|January 5, 2021
Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 casesCésar Sánchez, Francisco Domínguez, Héctor Galindo, et al.Frontiers in Immunology|August 1, 2020
Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer PatientsJavier Valdés-Ferrada, Natalia Muñoz-Durango, Alejandra Pérez-Sepulveda, et al.Breast Cancer Research and Treatment|January 23, 2019
Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?Suzanne B Coopey, Kinyas Kartal, Clara Li, et al.BMJ Open|August 10, 2025
Challenges of cancer survivorship care in Chile: a longitudinal study comparing the quality of care and quality of life for cancer survivors in a primary care network and a cancer centre in ChileKlaus Puschel, Victor Arancibia, Andrea Rioseco, et al.Ecancermedicalscience|July 8, 2026
Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclinesFrancisco Acevedo, Benjamín Walbaum, Lidia Medina, et al.Nutrition (Burbank, Los Angeles County, Calif.)|March 2, 2024
High linoleic acid levels in red blood cells predict a poor response to neoadjuvant chemotherapy in human epidermal growth factor receptor type 2-positive breast cancer patientsRodrigo Valenzuela, Benjamín Walbaum, Camila Farias, et al.Breast Cancer Research and Treatment|November 22, 2022
Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world studyFrancisco Acevedo, Benjamín Walbaum, Lidia Medina, et al.Pageof 7